Clinical Trials Directory

Trials / Completed

CompletedNCT05244954

Comparing Chemoprevention Approaches for School-based Malaria Control

Clinical Trial to Evaluate Intermittent Screening and Treatment and Intermittent Preventive Treatment of Malaria in Asymptomatic Schoolchildren to Decrease P. Falciparum Infection and Transmission

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
746 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
Accepted

Summary

This is an individually randomized, controlled, single blind three arm clinical trial of malaria chemoprevention strategies Arm 1: Intermittent screening and treatment (IST) - students will receive treatment if they have a positive high sensitivity rapid diagnostic test (RDT). Arm 2: Intermittent preventive treatment (IPT) - all students will receive treatment. Arm 3: Control - students will receive standard of care (no preventive treatment). Outcomes include P. falciparum infection and parasite density, gametocyte carriage and gametocyte density, anemia, cognitive function and educational testing, as well as infection prevalence in student's households to assess the impact on transmission.

Detailed description

Students will be enrolled in a single primary school in Machinga District, Malawi. The intervention will be conducted every 6-weeks during the two school terms which coincide with peak malaria transmission. Students in the IPT are and those that test positive in the IST arm will be treatment with dihydroartemisinin-piperaquine (DP) (females less than 10 years old and all males) or chloroquine (females 10 years old or older).

Conditions

Interventions

TypeNameDescription
DRUGDihydroartemisinin-PiperaquineTreatment of females less than 10 years old and all males in Arm 2 and those who test positive in Arm 1.
DRUGChloroquineTreatment of females 10 years old and older in Arm 2 and those who test positive in Arm 1.

Timeline

Start date
2022-02-01
Primary completion
2022-08-26
Completion
2022-08-26
First posted
2022-02-17
Last updated
2022-11-15

Locations

1 site across 1 country: Malawi

Source: ClinicalTrials.gov record NCT05244954. Inclusion in this directory is not an endorsement.